Intermittent claudication limping
Conditions
Interventions
None listed
Sponsors
Ikazia Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: As this study is a continuation of the CETAC study the inclusion criteria have been described extensively in the CETAC study.
Exclusion criteria
Exclusion criteria: As this study is a continuation of the CETAC study the exclusion criteria have been described extensively in the CETAC study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| maximum walking distance | — |
Secondary
| Measure | Time frame |
|---|---|
| preference based utilities (EQ-5Dand Rating Scale), health status QoL scores (SF-36 and VascuQol), ankle-brachial index, maximum painless walking distance, clinical success, risk factor score, number of events, patency rates | — |
Countries
Netherlands
Outcome results
None listed